Singapore is often held up as a model for efficient and high-quality healthcare. A look at the numbers and trends helps us understand where pharmaceutical partners like Taj Pharma can contribute meaningfully.

In 2025, the Singapore government has allocated S$20.9 billion toward healthcare spending.

This is second only to defense in the national budget. Projections suggest that by 2030, healthcare spending could approach S$30 billion per year as demographic pressures (particularly an ageing population) increase demand.

Government health expenditure is rising both in absolute terms and as a share of GDP.

To help families manage costs, the government increases subsidies, expands MediSave/MediShield withdrawals, and boosts support for long-term care and elder care.

Major Health Issues & Disease Burden in Singapore

Understanding what diseases are most prevalent helps tailor medicine supply, public health interventions, and patient education.

ConditionStatistics / Trends
Hyperlipidaemia (high cholesterol / lipids)~ 39.1 % of adults aged 18-69 years in recent years.Ministry of Health
Hypertension~ 37 % among adults aged 18-69.Ministry of Health
DiabetesPrevalence is around 8-10 % in similar adult age groups.Ministry of Health
ObesityRising: 8.6 % (earlier) to ~ 11.6 %.Ministry of Health
Smoking (daily smokers)Around ~ 9-10 %. Slight fluctuations.Ministry of Health
CancersAmong leading incidences: prostate (for men), breast (for women), colon & rectum for both sexes.Ministry of Health
Other chronic and non-communicable diseases (NCDs) such as cardiovascular, metabolic (e.g. high blood lipids, hypertension, type 2 diabetes) are increasingly dominant over infectious diseases.

Singapore’s Medical / Pharmacy Dispensing System

While the precise list of medicines provided by a specific manufacturer (like Taj Pharma) to Singapore is not public in full detail, some general practices in Singapore are:

  • Public hospitals and polyclinics provide subsidised medicines for patients, especially for chronic diseases. Patients often pay less depending on means and subsidy tiers.
  • There is a national framework combining MediSave (medical savings), MediShield Life (insurance), and Medifund (a safety net fund) to ensure affordability.
  • Outpatient subsidies are being expanded. For example, eligibility and amounts for MediSave withdrawal for outpatient scans and treatments are being increased.

Taj Pharma: What We Offer

Taj Pharma is well positioned to support Singapore’s health needs by providing quality medicines, innovations, and partnerships.

Product Range

Taj Pharma’s portfolio includes a wide range of therapeutic categories, including but not limited to:

  • Cardiovascular
  • Anti-infectives (antibiotics, antivirals)
  • Central Nervous System (CNS) agents (antidepressants, antiepileptics, etc.)
  • Anti-inflammatory
  • Oncology (cancer medicines)
  • Anti-diabetic medicines
  • Analgesics / Pain management
  • Dermatology, respiratory health, women’s healthcare, etc.

Manufacturing Quality & Capacity

  • All manufacturing done via WHO-GMP, GLP, ISO-certified partners.

Diverse dosage forms: tablets, capsules, dry syrups, liquid injections, soft gelatin capsules, ointments/creams, external liquids, etc.

Capability to produce both human pharmaceuticals and veterinary medicines.

New / Notable Products

Some of the more recent generics & products include:

  • Escitalopram, Olanzapine, Quetiapine (CNS)
  • Lipid-lowering drugs such as Atorvastatin / Fenofibrate, and Rosuvastatin
  • Anti-ulcer (Esomeprazole)
  • Anti-obesity agents (Orlistat)

These kinds of medicines are quite relevant given Singapore’s disease burden (e.g. cardiovascular disease, obesity, metabolic disorders, mental health).

Fenbendazole Tablets 500mg Manufacturer & Suppliers in India
Fenbendazole Tablets 500mg

Taj Pharma’s Vision & Mission (Singapore Context)

  • Vision: To provide high-quality, affordable, and innovative pharmaceutical solutions globally, including Singapore, where quality, safety, and efficacy are paramount.
  • Mission: To prevent, diagnose, alleviate, and cure diseases by discovering, developing and marketing medicines that meet global standards; to ensure patient well-being through access, reliability, transparency and innovation.

How Taj Pharma Aligns With Patient Needs in Singapore

From a patient perspective, here’s how Taj Pharma helps address the needs:

  1. Affordability: By offering generics and competitively priced medicines, Taj Pharma can help reduce out-of-pocket costs for chronic condition management.
  2. Availability: Wide therapeutic categories and multiple dosage forms increase the likelihood that needed medicines are available locally.
  3. Quality assurance: Certifications and manufacturing transparency build trust among patients, healthcare providers, and regulators.
  4. Supporting national priorities: Medicines for diseases like diabetes, hypertension, obesity, mental health, etc., are among Singapore’s high disease burden; Taj Pharma’s portfolio includes such drugs.
  5. Partnership potential: For national medical pharmacies, bulk tendering, hospital supply, or outpatient dispensing, Taj Pharma can be a partner in ensuring supply chain reliability.

Key Contact & Support

For inquiries, bulk orders, or information about specific medicines, patients or institutions can reach Taj Pharma through:

We welcome enquiries from Singaporean hospitals, clinics, pharmacies, and patient groups to discuss how Taj Pharma can support access to essential medications.

Singapore’s healthcare system is strong and well-funded, but facing growing demand from aging, lifestyle-driven chronic illnesses. Affordable, quality medicines are a cornerstone of sustainable healthcare. Taj Pharma, with its broad product range, certified manufacturing, patient-centred focus and commitment to affordability, is well placed to contribute significantly to improving health outcomes in Singapore.